Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Design Therapeutics, Inc. | Director | Common Stock | 133K | $312K | $2.35 | Sep 29, 2023 | Direct |
Design Therapeutics, Inc. | Director | Stock Option (right to buy) | 19K | Jun 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DSGN | Design Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
DSGN | Design Therapeutics, Inc. | Dec 1, 2023 | 1 | $0 | 4 | Dec 5, 2023 | Director |
DSGN | Design Therapeutics, Inc. | Sep 29, 2023 | 1 | $49.3K | 4 | Oct 2, 2023 | Director |
DSGN | Design Therapeutics, Inc. | May 31, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
DSGN | Design Therapeutics, Inc. | Dec 9, 2022 | 1 | $119K | 4 | Dec 12, 2022 | Director |
DSGN | Design Therapeutics, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |